An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.

The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...

(RTTNews) - Johnson & Johnson (JNJ) Wednesday said it has initiated the submission of new drug application or NDA to Food and Drug Administration (FDA) for TAR-200 to treat patients with Bacillus ...

Johnson & Johnson announced it has initiated the submission of an original New Drug Application with the U.S. FDA for TAR-200 for the ...

The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% ...

The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...

But on Monday, UNC football redshirt junior DeAndre Boykins became the 18th Tar Heel in this year's transfer portal. Due to ...

The Food and Drug Administration is banning the use of Red No. 3, an artificial dye linked to cancer in animals, from food and ingested drugs. Johnson & Johnson initiated an application seeking Food ...

No. 20 Duke women’s swim fell to the 17th-ranked Tar Heels 178-114, while the men’s side fell to No. 12 North Carolina ...

The industry-academia collaboration with Sunton Power Sdn Bhd was sealed with the memorandum of understanding (MOU) signed at ...

A pair of bitter ACC rivals face off for the first of two meetings this season on Thursday, Jan. 9 when the No. 19 UNC Tar Heels host the No. 14 Duke Blue Devils at Carmichael Arena in Chapel Hill, ...